Literature DB >> 17438030

Evaluation of the role of LcrV-Toll-like receptor 2-mediated immunomodulation in the virulence of Yersinia pestis.

Kimberly Pouliot1, Ning Pan, Shixia Wang, Shan Lu, Egil Lien, Jon D Goguen.   

Abstract

Pathogenic members of the Yersinia genus require the translocator protein LcrV for proper function of the type III secretion apparatus, which is crucial for virulence. LcrV has also been reported to play an independent immunosuppressive role via the induction of interleukin-10 (IL-10) through stimulation of Toll-like receptor 2 (TLR2). To investigate the LcrV-TLR2 interaction in vitro, His-tagged recombinant LcrV (rLcrV) from Yersinia pestis was cloned and expressed in Escherichia coli and purified through Ni-nitrilotriacetic acid column chromatography. High concentrations (5 microg/ml) of rLcrV stimulated TLR2 in vitro. Fractionation of rLcrV preparations via gel filtration revealed that only a minor component consisting of high-molecular-weight multimers or aggregates has TLR2 stimulating activity. Dimer and tetramer forms of rLcrV, which constitute the bulk of the material, do not have this activity. To investigate the potential role of LcrV/TLR2 in plague pathogenesis, we infected wild-type and TLR2(-/-) mice with virulent Y. pestis. No discernible difference between the two mouse strains in severity of disease or kinetics of survival after subcutaneous challenge was observed. IL-6, tumor necrosis factor, and IL-10 levels from spleen homogenates; bacterial load; and the extent of inflammation observed in organs from mice infected intravenously were also indistinguishable in both mouse strains. Taken together, our data indicate that the most abundant molecular species of Y. pestis LcrV do not efficiently activate TLR2-signaling and that TLR2-mediated immunomodulation is unlikely to play a significant role in plague.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17438030      PMCID: PMC1932965          DOI: 10.1128/IAI.01644-06

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  34 in total

1.  Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components.

Authors:  O Takeuchi; K Hoshino; T Kawai; H Sanjo; H Takada; T Ogawa; K Takeda; S Akira
Journal:  Immunity       Date:  1999-10       Impact factor: 31.745

2.  LcrV is a channel size-determining component of the Yop effector translocon of Yersinia.

Authors:  A Holmström; J Olsson; P Cherepanov; E Maier; R Nordfelth; J Pettersson; R Benz; H Wolf-Watz; A Forsberg
Journal:  Mol Microbiol       Date:  2001-02       Impact factor: 3.501

3.  A surface protease and the invasive character of plague.

Authors:  O A Sodeinde; Y V Subrahmanyam; K Stark; T Quan; Y Bao; J D Goguen
Journal:  Science       Date:  1992-11-06       Impact factor: 47.728

4.  The V-antigen of Yersinia forms a distinct structure at the tip of injectisome needles.

Authors:  Catherine A Mueller; Petr Broz; Shirley A Müller; Philippe Ringler; Françoise Erne-Brand; Isabel Sorg; Marina Kuhn; Andreas Engel; Guy R Cornelis
Journal:  Science       Date:  2005-10-28       Impact factor: 47.728

Review 5.  Pathogen recognition and innate immunity.

Authors:  Shizuo Akira; Satoshi Uematsu; Osamu Takeuchi
Journal:  Cell       Date:  2006-02-24       Impact factor: 41.582

6.  Cutting edge: repurification of lipopolysaccharide eliminates signaling through both human and murine toll-like receptor 2.

Authors:  M Hirschfeld; Y Ma; J H Weis; S N Vogel; J J Weis
Journal:  J Immunol       Date:  2000-07-15       Impact factor: 5.422

7.  LcrV plague vaccine with altered immunomodulatory properties.

Authors:  Katie A Overheim; R William Depaolo; Kristin L Debord; Elizabeth M Morrin; Debra M Anderson; Nathaniel M Green; Robert R Brubaker; Bana Jabri; Olaf Schneewind
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

8.  Virulence factors of Yersinia pestis are overcome by a strong lipopolysaccharide response.

Authors:  Sara W Montminy; Naseema Khan; Sara McGrath; Mitchell J Walkowicz; Fiona Sharp; Joseph E Conlon; Koichi Fukase; Shoichi Kusumoto; Charles Sweet; Kensuke Miyake; Shizuo Akira; Robert J Cotter; Jon D Goguen; Egil Lien
Journal:  Nat Immunol       Date:  2006-09-17       Impact factor: 25.606

9.  A hypervariable N-terminal region of Yersinia LcrV determines Toll-like receptor 2-mediated IL-10 induction and mouse virulence.

Authors:  Andreas Sing; Dagmar Reithmeier-Rost; Kaisa Granfors; Jim Hill; Andreas Roggenkamp; Jürgen Heesemann
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-20       Impact factor: 11.205

10.  Growth of Yersinia pseudotuberculosis in mice occurs independently of Toll-like receptor 2 expression and induction of interleukin-10.

Authors:  Victoria Auerbuch; Ralph R Isberg
Journal:  Infect Immun       Date:  2007-04-09       Impact factor: 3.441

View more
  27 in total

1.  Evaluation of Psn, HmuR and a modified LcrV protein delivered to mice by live attenuated Salmonella as a vaccine against bubonic and pneumonic Yersinia pestis challenge.

Authors:  Christine G Branger; Wei Sun; Ascención Torres-Escobar; Robert Perry; Kenneth L Roland; Jacqueline Fetherston; Roy Curtiss
Journal:  Vaccine       Date:  2010-10-24       Impact factor: 3.641

2.  Diminished LcrV secretion attenuates Yersinia pseudotuberculosis virulence.

Authors:  Jeanette E Bröms; Matthew S Francis; Ake Forsberg
Journal:  J Bacteriol       Date:  2007-09-14       Impact factor: 3.490

Review 3.  Interaction between Yersinia pestis and the host immune system.

Authors:  Bei Li; Ruifu Yang
Journal:  Infect Immun       Date:  2008-02-04       Impact factor: 3.441

4.  Amino acid and structural variability of Yersinia pestis LcrV protein.

Authors:  Andrey P Anisimov; Svetlana V Dentovskaya; Evgeniy A Panfertsev; Tat'yana E Svetoch; Pavel Kh Kopylov; Brent W Segelke; Adam Zemla; Maxim V Telepnev; Vladimir L Motin
Journal:  Infect Genet Evol       Date:  2009-10-14       Impact factor: 3.342

5.  Protective immunity against a lethal respiratory Yersinia pestis challenge induced by V antigen or the F1 capsular antigen incorporated into adenovirus capsid.

Authors:  Julie L Boyer; Carolina Sofer-Podesta; John Ang; Neil R Hackett; Maria J Chiuchiolo; Svetlana Senina; David Perlin; Ronald G Crystal
Journal:  Hum Gene Ther       Date:  2010-07       Impact factor: 5.695

6.  Substrains of 129 mice are resistant to Yersinia pestis KIM5: implications for interleukin-10-deficient mice.

Authors:  Joshua K Turner; John L Xu; Richard I Tapping
Journal:  Infect Immun       Date:  2008-10-27       Impact factor: 3.441

7.  Toll-like receptor 6 drives differentiation of tolerogenic dendritic cells and contributes to LcrV-mediated plague pathogenesis.

Authors:  R William Depaolo; Fangming Tang; Inyoung Kim; Mei Han; Nadine Levin; Nancy Ciletti; Anning Lin; Debra Anderson; Olaf Schneewind; Bana Jabri
Journal:  Cell Host Microbe       Date:  2008-10-16       Impact factor: 21.023

8.  Amino acid substitutions in LcrV at putative sites of interaction with Toll-like receptor 2 do not affect the virulence of Yersinia pestis.

Authors:  Wei Sun; Roy Curtiss
Journal:  Microb Pathog       Date:  2012-07-24       Impact factor: 3.738

9.  Immunization with recombinant V10 protects cynomolgus macaques from lethal pneumonic plague.

Authors:  Claire A Cornelius; Lauriane E Quenee; Katie A Overheim; Frederick Koster; Trevor L Brasel; Derek Elli; Nancy A Ciletti; Olaf Schneewind
Journal:  Infect Immun       Date:  2008-09-15       Impact factor: 3.441

10.  Bordetella evades the host immune system by inducing IL-10 through a type III effector, BopN.

Authors:  Kanna Nagamatsu; Asaomi Kuwae; Tadashi Konaka; Shigenori Nagai; Sei Yoshida; Masahiro Eguchi; Mineo Watanabe; Hitomi Mimuro; Shigeo Koyasu; Akio Abe
Journal:  J Exp Med       Date:  2009-12-14       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.